95970-0SARS-CoV-2 (COVID-19) specific TCRB gene rearrangements [Presence] in Blood by SequencingActive
Term Description
This term is intended to report assays that apply disease-specific algorithms to the sequence information from rearranged T-cell receptor beta (TCRB) gene (i.e., the T-cell receptor repertoire) to assign a qualitative result that determines recent or prior infection by SARS-CoV-2.
Source: Regenstrief LOINC
Part Description
LP150045-5 Sequencing
Sequencing is a method used to determine the sequence of individual genes, larger genetic regions (i.e. clusters of genes or operons), full chromosomes or entire genomes. Historically, most sequencing has been performed using the chain termination method developed by Frederick Sanger in 1977.[PMID:271968] Sequencing technologies have improved dramatically, making them cheaper, faster, and more accurate. Next-generation sequencing (NGS), also known as high-throughput sequencing, deep sequencing, and second-generation sequencing, is a type of technology that uses parallel sequencing of multiple small fragments of DNA to determine sequence. This "high-throughput" technology has increased the speed and amount of DNA sequenced at a significantly reduced cost.[PMID:18576944] Several NGS platforms (ie, sequencing instruments and associated reagents) have been developed. Third-generation sequencing is another methodology currently under development that uses parallel sequencing similar to NGS. In contrast to NGS, third-generation sequencing uses single DNA molecules rather than amplified DNA as a template.[PMID:20858600]
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- SARS coronavirus 2 specific TCRB gene rearrangements
- Property
- PrThr
- Time
- Pt
- System
- Bld
- Scale
- Ord
- Method
- Sequencing
Additional Names
- Short Name
- SARS-CoV-2 TCRB Bld Ql Seq
- Display Name
- SARS-CoV-2 (COVID-19) specific TCRB gene rearrangements Sequencing Ql (Bld)
- Consumer Name Alpha
- SARS-CoV-2 (COVID-19) specific TCRB gene rearrangements, Blood
Example Answer List LL2021-5
Source: Gen-Probe
Answer | Code | Score | Answer ID |
---|---|---|---|
Positive Copyright http://snomed.info/sct ID:10828004 Positive (qualifier value) | LA6576-8 | ||
Negative Copyright http://snomed.info/sct ID:260385009 Negative (qualifier value) | LA6577-6 | ||
Invalid Copyright http://snomed.info/sct ID:455371000124106 Invalid result (qualifier value) | LA15841-2 |
Basic Attributes
- Class
- MICRO
- Type
- Laboratory
- First Released
- Version 2.69
- Last Updated
- Version 2.69
- Order vs. Observation
- Both
Reference Information
Type | Source | Reference |
---|---|---|
Webcontent | Lab Tests Online®Copyright Copyright © 2021 Lab Tests Online. All rights reserved. | Coronavirus (COVID-19) Testing |
Member of these Groups
LG51017-8 | SARSCoV2 detection |
LG51019-4 | SARSCoV2 molecular detection |
Language Variants Get Info
- zh-CNChinese (China)
- SARS 冠状病毒 2 特异性 TCRB 基因重排:
存在情况或阈值: 时间点: 全血: 序数型: 序列测定 - nl-NLDutch (Netherlands)
- SARS-CoV-2-specifieke TCRB-gentranslocaties:
aanwezigheid: moment: bloed: ordinaal: sequencing - fr-FRFrench (France)
- Coronavirus SARS-CoV-2 réarrangements gène TCRB:
Présence/Seuil: Ponctuel: Sang: Qualitatif: Séquençage - de-DEGerman (Germany)
- SARS-Coronavirus 2-spezifische TCRB Gen-Rearrangements:
Nachweis oder Schwellenwert: Zeitpunkt: Blut: Ordinal: Sequenzierung - it-ITItalian (Italy)
- SARS coronavirus 2, specifici riarrangiamenti del gene TCRB:
PrThr: Pt: Sangue: Ord: Sequenziamento - pl-PLPolish (Poland)
- rearanżacja specyficznego genu TCRB SARS-CoV-2:
obecność lub wartość progowa: Punkt w czasie: Krew: Porządkowy: Sekwencjonowanie - es-MXSpanish (Mexico)
- Reordenamientos del gen TCRB específicos del coronavirus 2 del SARS:
Presencia o umbral: Punto temporal: Sangre: Ordinal: Secuenciación - es-ESSpanish (Spain)
- Reordenamientos genéticos específicos de TCRB del SARS-CoV-2 (COVID-19):
PrThr: Punto temporal: Sangre: Ord: Secuenciación
LOINC FHIR® API Example - CodeSystem Request Get Info
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=95970-0
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright